XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Authority Hl7

42,405 resources

By Version

R2: 0
R2B: 0
R3: 2,217
R4: 26,023
R4B: 2,734
R5: 11,207
R6: 224

By Realm

none: 3,411
au: 272
be: 387
ca: 138
ch: 1,482
cl: 469
cr: 45
cz: 384
de: 190
dk: 88
ee: 155
eu: 1,173
fi: 87
fr: 120
in: 29
it: 181
kr: 5
nl: 929
no: 26
nz: 79
pl: 83
se: 22
stt: 116
us: 17,481
uv: 14,773
vn: 107
other: 7

Start Prev Rows 26600 - 26800 Next

Package	Version	Identity	Name/Title	Status	Date	Realm
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1973	Hepatitis D Virus Infection (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1974	Baylisascariasis (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1975	Baylisascariasis (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1976	Baylisascariasis (Tests for Baylisascaris species Antibody)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1978	Larva Migrans (Neural, Ocular, or Visceral) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1979	Larva Migrans (Neural, Ocular, or Visceral) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1980	California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1981	California Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1982	California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1983	California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1984	California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1985	California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1986	Pregnant (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1987	Flank Pain (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1988	Bone Pain (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1989	Abscess (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1990	Abscess (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1991	Focal Brain Lesions (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1992	Pathologic Fractures [Unspecified Cause] (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1993	Pathologic Fractures [Unspecified Cause] (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1994	Granulomas (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1995	Granulomas (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1996	Skin Lesions (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1997	Skin Lesions (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1998	Angiostrongyliasis (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1999	Lymphocytic Choriomeningitis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2000	Lymphocytic Choriomeningitis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2001	Lymphocytic Choriomeningitis (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2002	Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2003	Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2004	Lymphocytic Choriomeningitis (Tests for LCMV Antibody)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2005	Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2006	Angiostrongyliasis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2007	Eosinophilic meningitis (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2009	Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2010	Eosinophils [Concentration] (Tests in CSF by Any Method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2011	Eosinophils [Percentage] (Tests in CSF by Any Method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2012	Mpox (Tests for mpox virus by Genomic Sequencing)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2013	Mpox (Test Panels for mpox virus by Genomic Sequencing)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2017	Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2018	Interpretation of an Observation (High)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2019	Interpretation of an Observation (Low)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.202	Trichinellosis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2020	Lymphadenopathy [Acute] (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2023	Tick Paralysis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2024	Bacillary angiomatosis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2025	Animal Bite or Scratch [Cat] (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2026	Animal Bite or Scratch [Cat] (Disorders) (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2027	Bartonellosis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2028	Bartonellosis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2029	Bartonellosis (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2030	Bartonella henselae infection (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2031	Bartonella quintana infection (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2032	Bartonella bacilliformis infection (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2033	Bartonella henselae infection (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2034	Bartonella quintana infection (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2036	Bartonella henselae (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2037	Bartonella quintana (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2038	Bartonella bacilliformis (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2039	Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.204	Giardiasis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2040	Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2041	Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2042	Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2043	Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2044	Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2045	Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2046	Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2047	Bartonellosis (Tests for Bartonella spp. Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2048	Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2049	Bartonella spp. (Tests by Microscopic Observation)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2050	Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2051	Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2052	Echinococcosis (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2053	Echinococcosis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2054	Cystic Echinococcosis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2055	Cystic Echinococcosis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2056	Alveolar Echinococcosis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2057	Alveolar Echinococcosis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2058	Echinococcosis (Tests for Echinococcus species Antibody)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2059	Echinococcus species (Tests by Microscopic Observation)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2060	Echinococcosis (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2061	Genital Warts (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2062	Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2063	Genital Warts (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2064	Diphyllobothriasis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2065	Diphyllobothriasis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2066	Diphyllobothriasis (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2067	Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2068	Angiostrongyliasis (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2069	Pelvic Inflammatory Disease (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2070	Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2071	Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2072	Pelvic Inflammatory Disease (Disorders) (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2073	Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2074	Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2075	Lower Abdominal Tenderness (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2076	Lower Abdominal Tenderness (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2077	Tenderness with motion of the cervix (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2078	Adnexal Tenderness (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2079	Uterine Tenderness (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2080	Leukocytosis (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2081	Leukocytosis (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2082	Purulent material in the peritoneal cavity (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2083	Pelvic Abscess (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2084	Pelvic Abscess (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2085	Leukocytes [Concentration] (Tests in Blood by Any Method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2087	Nongonococcal Urethritis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2088	Nongonococcal Urethritis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2089	Urethritis (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2090	Urethritis (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2091	Urethral discharge (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2092	Urethral discharge (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2093	Dysuria (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2094	Dysuria (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2095	Gonorrhea (Tests for Neisseria gonorrhoeae Antigen)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2096	Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2098	Rhinitis (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2100	Rhinitis (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2101	Pleuritis (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2102	Pleuritis (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2103	Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2105	Methemoglobinemia (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2106	Methemoglobinemia [Non Congenital] (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2107	Methemoglobinemia (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2108	Methemoglobinemia [Non Congenital] (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2109	Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative])	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2110	Anencephaly (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2111	Anencephaly (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2112	Fetal Anencephaly (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2113	Fetal Anencephaly (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2114	Cleft Lip Alone (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2115	Cleft Lip Alone (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2116	Fetal Cleft Lip (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2117	Cleft Palate Alone (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2118	Cleft Palate Alone (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2119	Cleft Lip with Cleft Palate (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2120	Cleft Lip with Cleft Palate (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2121	Fetal Spina Bifida (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2122	Spina Bifida (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2123	Spina Bifida (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2124	Down Syndrome (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2125	Down Syndrome (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2126	Fetal Down Syndrome (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2127	Fetal Down Syndrome (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2128	Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2129	Bacteremia (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2130	Bacteremia (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2131	Gastroschisis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2132	Gastroschisis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2133	Fatal Familial Insomnia (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2134	Fatal Familial Insomnia (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2135	Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2136	Gerstmann Straussler Scheinker Syndrome (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2137	Prion Disease (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2138	Prion Disease (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2139	Prion Disease (Tests for Abnormal PRNP Gene Variant)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2140	Phenylketonuria (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2141	Phenylketonuria (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2145	Tuberculosis [Suspected] (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2146	Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2147	Limb Reduction (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2148	Limb Reduction (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2149	NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2150	Congenital Hearing Loss (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2151	Congenital Hearing Loss (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2152	Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2153	Primary Congenital Hypothyroidism (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2154	Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2155	Congenital Hypothyroidism [Unspecified] (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2156	Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2157	Mpox (Combination Tests that include mpox virus Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2158	Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2159	Mpox (Test Panels for mpox virus Nucleic Acid)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.216	Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody])	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2160	Orthopox (Test Panels for orthopoxvirus Nucleic Acid)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2161	COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2163	Dengue Virus Infection [Suspected] (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2164	Mumps [Suspected] (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2165	Pertussis [Suspected] (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2166	Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2167	Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2168	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2169	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2170	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2171	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2172	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2173	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2174	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2175	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2176	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2177	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2178	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2179	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.218	Listeriosis (Disorders) (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2180	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2181	Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2183	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2187	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2188	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid)	active	2024-06	us